JP Morgan Maintains Overweight on Nuvalent, Raises Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anupam Rama maintains an Overweight rating on Nuvalent (NASDAQ:NUVL) and raises the price target from $51 to $68.
October 05, 2023 | 2:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on Nuvalent and raises the price target from $51 to $68, indicating a positive outlook for the stock.
The raised price target by JP Morgan indicates a positive outlook for Nuvalent. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100